Drug profile · INN
rucaparib camsylate
RUBRACA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
rucaparib camsylate (RUBRACA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN rucaparib camsylate
Brand RUBRACA
Route ORAL
Formulation TABLET
Frequently asked questions
What is rucaparib camsylate?
rucaparib camsylate (RUBRACA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for rucaparib camsylate?
RUBRACA is a marketed brand name for rucaparib camsylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of rucaparib camsylate?
rucaparib camsylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.